The AFINITOR Co-Pay Card
Novartis Pharmaceuticals Corporation is committed to helping make treatment with AFINITOR® (everolimus) Tablets as affordable as possible. For patients with commercial insurance, we offer the AFINITOR Co-Pay Card, which provides eligible patients with a way to lower out-of-pocket costs for their treatment.
How may the AFINITOR Co-Pay Card help with my out-of-pocket costs?
MOST ELIGIBLE PATIENTS PAY NO MORE THAN $25 A MONTH FOR AFINITOR WITH THE AFINITOR CO-PAY CARD.
For most eligible patients, the co-pay for your AFINITOR prescription will be no more than $25 for each 28-day prescription. Novartis will pay the remainder of your co-pay for AFINITOR, up to a maximum of $6350 per month, every month that you remain on treatment with AFINITOR. This program expires on December 31, 2015.
Limitations apply. See Program Terms and Conditions. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice.
What if I'm not eligible for the AFINITOR Co-Pay Card?
If you answered "no" to any of the above statements, or if you are otherwise ineligible for the AFINITOR Co-Pay Card, there are other ways we can help to make treatment with AFINITOR as affordable as possible. See the information on our Patient Assistance NOW Oncology (PANO) support programs.
How do I get my AFINITOR Co-Pay Card?
To take advantage of these savings, if you are eligible, simply print out the AFINITOR Co-Pay Card and take it with you to your pharmacy. This program will expire on December 31, 2015.
Register for M.O.R.E
Get access to more ongoing support, including calls with an oncology nurse and informative e-mails.
Why consider AFINITOR?
Learn about the potential benefits and risks of treatment with AFINITOR.